[HTML][HTML] Comparative Effectiveness and Safety of Direct Oral Anticoagulants Compared with Warfarin in Patients with Low Bodyweight who have Atrial Fibrillation: A …
MN Elshafei, A El-Bardissy, M Salem… - American Journal of …, 2024 - Springer
Introduction oral anticoagulant (DOAC) agents are becoming the anticoagulation strategy of
choice for most clinical risks for which they are indicated. However, residual uncertainty …
choice for most clinical risks for which they are indicated. However, residual uncertainty …
Comparative Effectiveness and Safety of Direct Oral Anticoagulants Compared with Warfarin in Patients with Low Bodyweight who have Atrial Fibrillation: A Systematic …
MN Elshafei, A El-Bardissy, M Salem… - American Journal of …, 2024 - europepmc.org
Methods We carried out a comprehensive search of electronic databases from inception to
June 2023 for eligible studies reporting on the efficacy and safety of direct oral …
June 2023 for eligible studies reporting on the efficacy and safety of direct oral …
[PDF][PDF] Comparative Effectiveness and Safety of Direct Oral Anticoagulants Compared with Warfarin in Patients with Low Bodyweight who have Atrial Fibrillation: A …
MN Elshafei, A El‑Bardissy, M Salem… - clinical …, 2024 - researchgate.net
Introduction oral anticoagulant (DOAC) agents are becoming the anticoagulation strategy of
choice for most clinical risks for which they are indicated. However, residual uncertainty …
choice for most clinical risks for which they are indicated. However, residual uncertainty …
[HTML][HTML] Comparative Effectiveness and Safety of Direct Oral Anticoagulants Compared with Warfarin in Patients with Low Bodyweight who have Atrial Fibrillation: A …
MN Elshafei, A El-Bardissy, M Salem… - American Journal of …, 2024 - ncbi.nlm.nih.gov
Methods We carried out a comprehensive search of electronic databases from inception to
June 2023 for eligible studies reporting on the efficacy and safety of direct oral …
June 2023 for eligible studies reporting on the efficacy and safety of direct oral …
Comparative Effectiveness and Safety of Direct Oral Anticoagulants Compared with Warfarin in Patients with Low Bodyweight who have Atrial Fibrillation: A Systematic …
MN Elshafei, A El-Bardissy, M Salem… - American journal of … - pubmed.ncbi.nlm.nih.gov
Introduction oral anticoagulant (DOAC) agents are becoming the anticoagulation strategy of
choice for most clinical risks for which they are indicated. However, residual uncertainty …
choice for most clinical risks for which they are indicated. However, residual uncertainty …
[PDF][PDF] Comparative Effectiveness and Safety of Direct Oral Anticoagulants Compared with Warfarin in Patients with Low Bodyweight who have Atrial Fibrillation: A …
MN Elshafei, A El‑Bardissy, M Salem… - clinical …, 2024 - researchgate.net
Introduction oral anticoagulant (DOAC) agents are becoming the anticoagulation strategy of
choice for most clinical risks for which they are indicated. However, residual uncertainty …
choice for most clinical risks for which they are indicated. However, residual uncertainty …
Comparative Effectiveness and Safety of Direct Oral Anticoagulants Compared with Warfarin in Patients with Low Bodyweight who have Atrial Fibrillation: A Systematic …
MN Elshafei, A El-Bardissy, M Salem… - American Journal of …, 2024 - europepmc.org
Methods We carried out a comprehensive search of electronic databases from inception to
June 2023 for eligible studies reporting on the efficacy and safety of direct oral …
June 2023 for eligible studies reporting on the efficacy and safety of direct oral …